Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Z Stanczyk

Showing results (61-70 of 383) with videos related to

Pageof 39
Sort By:
Contraception|December 3, 2011
Ethinyl estradiol and levonorgestrel pharmacokinetics with a low-dose transdermal contraceptive delivery system, AG200-15: a randomized controlled trialDavid F Archer, Frank Z Stanczyk, Arkady Rubin, et al.
Contraception|December 12, 2012
Therapeutically equivalent pharmacokinetic profile across three application sites for AG200-15, a novel low-estrogen dose contraceptive patchFrank Z Stanczyk, David F Archer, Arkady Rubin, et al.
Menopause (New York, N.Y.)|October 17, 2023
Comparative estrogen exposure from compounded transdermal estradiol creams and Food and Drug Administration-approved transdermal estradiol gels and patchesMark S Newman, Doreen Saltiel, Jaclyn Smeaton, et al.
The Prostate|July 12, 2002
Hormones and prostate cancer: current perspectives and future directionsAnn W Hsing, Juergen K V Reichardt, Frank Z Stanczyk
Contraception|September 20, 2006
Effects of transdermal and oral contraceptives on estrogen-sensitive hepatic proteinsTerry White, Begüm Ozel, John K Jain, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 9, 2012
Night shift work and hormone levels in womenScott Davis, Dana K Mirick, Chu Chen, et al.
Annals of Epidemiology|February 7, 2006
Effects of 60-Hz magnetic field exposure on nocturnal 6-sulfatoxymelatonin, estrogens, luteinizing hormone, and follicle-stimulating hormone in healthy reproductive-age women: results of a crossover trialScott Davis, Dana K Mirick, Chu Chen, et al.
Contraception|February 18, 2010
Antimullerian hormone and obesity: insights in oral contraceptive usersAnne Z Steiner, Frank Z Stanczyk, Stan Patel, et al.
Contraception|September 24, 2014
Increased exposure of norethindrone in HIV+ women treated with ritonavir-boosted atazanavir therapyBarent N DuBois, Jessica Atrio, Frank Z Stanczyk, et al.
Steroids|April 25, 2024
Metabolism of progestogens used for contraception and menopausal hormone therapyFrank Z Stanczyk, Alexandra McGough, Laura Chagam, et al.
Pageof 39

Showing results (61-70 of 383) with videos related to

Sort By:
Pageof 39
Contraception|December 3, 2011
Ethinyl estradiol and levonorgestrel pharmacokinetics with a low-dose transdermal contraceptive delivery system, AG200-15: a randomized controlled trialDavid F Archer, Frank Z Stanczyk, Arkady Rubin, et al.
Contraception|December 12, 2012
Therapeutically equivalent pharmacokinetic profile across three application sites for AG200-15, a novel low-estrogen dose contraceptive patchFrank Z Stanczyk, David F Archer, Arkady Rubin, et al.
Menopause (New York, N.Y.)|October 17, 2023
Comparative estrogen exposure from compounded transdermal estradiol creams and Food and Drug Administration-approved transdermal estradiol gels and patchesMark S Newman, Doreen Saltiel, Jaclyn Smeaton, et al.
The Prostate|July 12, 2002
Hormones and prostate cancer: current perspectives and future directionsAnn W Hsing, Juergen K V Reichardt, Frank Z Stanczyk
Contraception|September 20, 2006
Effects of transdermal and oral contraceptives on estrogen-sensitive hepatic proteinsTerry White, Begüm Ozel, John K Jain, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 9, 2012
Night shift work and hormone levels in womenScott Davis, Dana K Mirick, Chu Chen, et al.
Annals of Epidemiology|February 7, 2006
Effects of 60-Hz magnetic field exposure on nocturnal 6-sulfatoxymelatonin, estrogens, luteinizing hormone, and follicle-stimulating hormone in healthy reproductive-age women: results of a crossover trialScott Davis, Dana K Mirick, Chu Chen, et al.
Contraception|February 18, 2010
Antimullerian hormone and obesity: insights in oral contraceptive usersAnne Z Steiner, Frank Z Stanczyk, Stan Patel, et al.
Contraception|September 24, 2014
Increased exposure of norethindrone in HIV+ women treated with ritonavir-boosted atazanavir therapyBarent N DuBois, Jessica Atrio, Frank Z Stanczyk, et al.
Steroids|April 25, 2024
Metabolism of progestogens used for contraception and menopausal hormone therapyFrank Z Stanczyk, Alexandra McGough, Laura Chagam, et al.
Pageof 39